
Anne Dragøy Hafstad
Job description
Anne D Hafstad is professor at the Cardiovascular Research Group, Department of Medical Biology. Her research interest is within experimental cardiac research with a focus on cardiac metabolism and the response to different cardiac stressors. She also teaches in many subjects within physiology at several courses, but mainly for medical students and odontology students. She is the leader for second year og medical school at the UiT and currently the group leader of the Cardiovascular Research Group.
The 50 latest publications is shown on this page. See all publications in Cristin here →
Publikasjoner utenom Cristin
Hafstad. AD. NADPH oksidaser i diabetisk hjertesykdom BestPractise. Diabetes/Hjerte-Kar sykdommer. Nr 26 2018. Review.
Hafstad A D. Trening kan bedre metabolske forstyrrelser ved diabetisk hjertesvikt. BestPractise. Diabetes/Hjerte-Kar sykdommer. Oktober 2015. Review.
Published peer-reviewed meetings abstracts and presentation at scientific meetings
M.A. Akhtar. C.F. Bryn , C.X.C. Santos, A.C. Visnagri, C.M. Reumiller, A. Zoccarato, A.M. Shah, Å. Birgisdottir, N.T. Boardman, A.D. Hafstad. Alterations in intermediary metabolism in Doxorubicin- and Trastuzumab-induced cardiotoxicity . Poster. 22nd annual meeting of the Society for Heart and Vascular Metabolism (SHVM), Bordeaux, France 22-25th of June 2025.
K. M. Lundqvist, M. A. Akthar, T. Lund, K. A. Fenton, H. L. Pedersen, A.D. Hafstad. MitoLupus: heart failure development and mitochondrial dynamics in Systemic Lupus Erythematosus (SLE). Short talk/selected abstract. 22nd annual meeting of the Society for Heart and Vascular Metabolism (SHVM), Bordeaux, France, 22-25th of June 2025.
M.A. Akhtar. C.F. Bryn , C.X.C. Santos, A.C. Visnagri, C.M. Reumiller, A. Zoccarato, A.M. Shah, Å. Birgisdottir, N.T. Boardman, A.D. Hafstad. Alterations in intermediary metabolism in Doxorubicin- and Trastuzumab-induced cardiotoxicity. Poster . Experimental Health Research Conference (EHRC) – UiT, Tromsø Norway, 16-17th of June 2025.
K.M. Lundqvist, M.A. Akthar, J. Konieczny, K. A. Fenton, H.L Pedersen, A.D. Hafstad. Investigating Cardiac Changes in Mouse Models of Systemic Lupus Erythematosus. Poster award winner. Experimental Health Research Conference (EHRC) – UiT, Tromsø Norway 16-17th of June 2025
K. M. Lundqvist, M. A. Akthar, T. Lund, K. A. Fenton, H. L. Pedersen, A.D. Hafstad. MitoLUPUS – experimental cardiac research in a SLE model. Oral presentation. NORHEART seminar, 12-13th of May 2025.
M.A. Akhtar, S. Ludvigsen, C. Mancusi A.D. Hafstad, E. Gerdts, K. Ytrehus. Role of sex hormones in modulating cardiovascular responses to fructose and high salt diet: insights from Dahl salt-sensitive rats. Poster award winner. Experimental Health Research Conference (EHRC) – UiT, Tromsø Norway, 19-20th of June 2024.
M.A. Akhtar, S Ludvigsen, C. Mancusi, A.D. Hafstad, E. Gerdts and K. Ytrehus. Role of sex hormones in modulating cardiovascular responses to fructose and high salt diet: insights from Dahl salt-sensitive rats. Poster. Physiology in Focus. Newcastle-upon-Tyne, UK 2.-4th of July 2024.
A.D. Hafstad. Anti-cancer therapy alters cardiac intermediary metabolism. Invited speaker. Annual Workshop on Breast Cancer Research. National Network for Breast Cancer Research. Stavanger, Norway. 19-20th of March 2024.
M.A. Akhtar, N.E. Taboko, C.X.C. Santos, A Visnagri, C. M. Reumiller, C.F. Bryn, Å. Birgisdottir, N.T. Boardman and A.D. Hafstad. Anti-cancer therapy alters cardiac intermediary metabolism. SPS, FEPS and Baltic physiological societies. Tallinn, Estonia, 14-16. September 2023.
M.A. Akhtar, N.E. Taboko, C.X.C. Santos, A Visnagri, C. M. Reumiller, C.F. Bryn, Å. Birgisdottir, N.T. Boardman and A.D. Hafstad. Anti-cancer therapy alters cardiac metabolism. Experimental Health Research Conference (EHRC) - Mímisbrunnr 2023. UiT, Norway. 21-22 June 2023
N. E. Taboko. M. A. Akhtar. C. F. Bryn, Å. B. Birgisdottir, A. D. Hafstad and N. T. Boardman. Evaluation of cardiac mitochondria morphological and bioenergetic changes following breast cancer treatment. Poster. Europhysiology 2022, Copenhagen, 16-18 September 2022.
M. A. Akhtar. Presentation. N. E. Taboko, C. F. Bryn, Å Birgisdottir, N. T. Boardman and A. D. Hafstad. Anti-cancer therapy alters cardiac metabolism. Poster. Europhysiology 2022, Copenhagen, Denmark, 16-18th of September 2022.
A.D. Hafstad. Cardiotoxicity following cancer treatment. Invited talk. 20th Annual Norwegian Symposium on Heart Research, Oslo. Norway, 8-9th of September 2022.
N. E. Taboko. M. A. Akhtar. C. F. Bryn, Å. B. Birgisdottir, N. T. Boardman and A. D. Hafstad. Metabolic, bioenergetic and mitochondrial changes in the heart following breast cancer treatment. 20th Annual Norwegian Symposium on Heart Research, Oslo. Norway, 8-9th of September 2022.
A. D. Hafstad. Establishing an animal model of cardiotoxicity induced by breast-cancer treatment. Oral. Networking meeting for breast cancer research in Tromsø, Norway. 26th of Oct 2021
A. D Hafstad. Cardiac metabolism in association with mitochondrial function. Invited speaker. Targeting Mitochondria in Cardiovascular Disease. NORHEART, UiO, Oslo, Norway. 9th of December 2021
C. F. Presentation. Bryn, T. Fiskaa , T. Lund and A.D. Hafstad Metabolic effects of breast cancer therapy on H9c2-myoblasts. Poster. 17th annual meeting of the Society for Heart and Vascular Metabolism (SHVM), Amsterdam, The Netherlands, 23-26 of June 2019.
T. Pedersen, E. Aasum, A.D. Hafstad, AngII-induced compensatory hypertrophy is associated with unaltered substrate utilization and efficiency in murine hearts. Poster. Acta Physiologica, 219 (2017) 20-20. Annual Meeting of the Scandinavian Physiological Society, University of Oslo, Oslo, Norway 26-28th of August 2016.
N. T. Boardman., A.D. Hafstad, L. Rossvoll, J. Lund, E. Aasum, Cardioprotection by exercise is not altered by high fatty acid levels. Poster. Acta Physiologica, 219 (2017) 23-23. Annual Meeting of the Scandinavian Physiological Society, University of Oslo, Norway. 26 28th of August 2016.
A.D. Hafstad. NADPH-oxidases in diabetic cardiomyopathy. Invited speaker. 12th annual meeting of the Society for Heart and Vascular Metabolism (SHVM), Beijing, China, 9-12th of October, 2016
A. Nabeebaccus, A.D. Hafstad, A. Zoccarato, T. Eykyn, J. West, J. Griffin, M. Mayr, A. Shah, NOX4- dependent reprogramming of glucose metabolism and fatty acid oxidation facilitates cardiac adaption to chronic pressure-overload. Poster. Heart, 102 (2016) A146-A146. Annual Conference of the British-Cardiovascular-Society (BCS) on Prediction and Prevention. Manchester, England, 6-8th of June 2016
S. S. Hansen, T. M. Pedersen, J. Lund, C. X. Santos, A.M. Shah, E. Aasum, A. D. Hafstad. NADPH oxidase inhibition affects mitochondrial ROS production in hearts from DIO mice. Poster. 11th annual meeting of the Society for Heart and Vascular Metabolism (SHVM), Tarrytown, USA, 4-7th of October 2015.
A Hafstad. The role of ROS (reactive oxygen species) in obesity related changes in cardiac function and metabolism. Oral. The 3rd International Workshop of The Female Heart Project, Tromsø, Norway, 17-18th of June 2015.
A. Nabeebaccus. A. D. Hafstad, T. Eykyn, X.K. Yin, A. Brewer, M. Zhang, M. Mayr, A. Shah, Cardiac-targeted NADPH oxidase 4 in the adaptive cardiac remodelling of the murine heart. Poster. Lancet, 385 (2015) 73-73. Spring Meeting for Clinician Scientists in Training 2015, London, UK, 26th of February 2015.
A.D. Hafstad, J. Lund, C.X. Santos, A. M. Shah and E Aasum. A role of NADPH oxidase in obesity-induced oxygen wasting. Poster. Gordon Conference Seminars on NOX Family NADPH Oxidases, Tuscany, Italy 18-23rd of May, 2014
A.D. Hafstad, J. Lund, C.X. Santos, A.M. Shah and Ellen Aasum. A role of NADPH oxidase in obesity-induced oxygen wasting. Oral. 11th annual meeting of the Society for Heart and Vascular Metabolism (SHVM), Tromsø, Norway, 24-27th of June 2014
E. S. Hadler-Olsen. A. I .Solli, A.D. Hafstad, J-O. Winberg, L. Uhlin-Hansen. Intracellular MMP-2 Activity in Skeletal Muscle is Associated with Type II Fibers. Poster. Gordon Research Conference on MMPs, Tuscany, Italy, 19-24th of May 2013.
A.D. Hafstad, J. Lund., T. S. Larsen, E. Aasum E. Exercise training prevents obesity-induced impairment of myocardial function and mechanoenergetics, as well as mitochondrial capacity and fatty acid-induced proton leak. Poster. 10th Annual CHFR Symposium, Oslo, Norway, 20-21th of September 2012.
A.C. Höper. T.S. Larsen, A.M Khalid, W. Salma, S.J. Sollie, A.D. Hafstad, E. Aasum, E. Low-dose supplementation with Calanus oil attenuates visceral adiposity and low-grade inflammation during high fat feeding. 3rd international congress on abdominal obesity. Brussels, Belgium, 9-12th of July 2012.
A.D. Hafstad, J. Lund, M. Hagve, E. S. Hadler-Olsen, A.C Höper, T.S. Larsen, E Aasum. High and moderate intensity training prevent diet-induced impairments in cardiac mechanoenergetics and ventricular function. Poster. 10th annual meeting of the Society for Heart and Vascular Metabolism (SHVM), Oxford, UK, 24-27th of June 2012.
J. Lund, A. D. Hafstad, T.S. Larsen, E. Aasum. High and moderate intensity training prevent obesity-related oxygen waste and development of left ventricular dysfunction in the presence of high fat. Oral. 10th annual meeting of the Society for Heart and Vascular Metabolism Oxford, UK (SHVM), 24-27th of June 2012.
A. Nabeebaccus., M Zhang, A.D. Hafstad, E. Aasum, X. Yin., A.C. Brewer, M. Mayr, A.M. Shah. NADPH oxidase-4 induces metabolic reprogramming in the murine heart in vivo. Oral. 10th Annual Scientific Sessions of the Society for Heart and Vascular Metabolism (SHVM), Oxford, UK, 24-27th of June 2012.
W. Salma, S.J. Sollie, A. C. Höper, A. M. Khalid, J. Lund, A.D. Hafstad, T.S. Larsen, E. Aasum. Wax ester purified from Calanus oil reduces visceral obesity and low-grade inflammation in adipose tissue during high fat feeding. Poster. 10th annual meeting of the Society for Heart and Vascular Metabolism (SHVM), Oxford, UK, 24-27th of June 2012.
W. Salma, S.J. Sollie, A.C. Höper, A.M. Khalid, J. Lund, A.D. Hafstad, T.S. Larsen, E Aasum. Dietary supplementation with Calanus oil reduces visceral fat deposition and improves insulin sensitivity during high fat feeding. Poster. 10th annual meeting of the Society for Heart and Vascular Metabolism Oxford (SHVM), 24-27th of June 2012.
K-H Kaspersen, N.T. Songstad, A.D. Hafstad, G. Acharya. High intensity training in pregnant rats. Poster. European Congress of Periantal Medicine, Paris, France, 13-16th of June 2012.
A.D. Hafstad, J. Lund, A.C. Höper, E.S. Hadler-Olsen, M. Hagve, U. Wisløff, T.S. Larsen, E. Aasum. Exercise improves ventricular function and decreases myocardial oxygen waste in diet-induced obese mice. Oral. Circulation 2011; Volum 124. ISSN 0009-7322.s A14938 . Scientific Sessions 2011 of the American Heart Association (AHA), Florida, Orlando, US, 12-16th of November 2011.
A.D. Hafstad, J. Lund, A.C. Höper, E.S. Hadler-Olsen, M. Hagve, U. Wisløff, T.S. Larsen, E. Aasum. High intensity interval training normalizes cardiac energetics and ventricular function in diet-induced obese mice. Oral. 9th annual meeting of the Society for Heart and Vascular Metabolism (SHVM), Brussels, Belgium, 17-21th of June 2011.
A.D Hafstad, N.T. Boardman, J. Lund, M. Hagve, U. Wisløff, T.S. Larsen, E. Aasum. Exercise-induced Increase In Cardiac Efficiency- The Impact of Intensity. Poster. Circulation; 120: S880. 2009. AHA Orlando, Florida, US, Nov. 14-18th of November 2009.
A.D. Hafstad, N.T. Boardman J. Lund, M. Hagve, U. Wisløff, T.S. Larsen, E. Aasum. Metabolic adaptations in the physiologically hypertrophied heart. 7th annual meeting of the Society for Heart and Vascular Metabolism (SHVM). Padova, Italy, 23-26th of August 2009.
E. Aasum, A.D. Hafstad, A.M. Khalid, R. Berge, T.S. Larsen. TTA - the first PPAR ligand shown to increase fatty acid oxidation in normal and diabetic myocardium when administered in vivo. Poster. ISHR, Heart failure 2009 30th May-, 2nd of June 2009.
K.O. Stenslokken, A. Rutkovsky, M.L. Kaijusto, A.D. Hafstad, T.S. Larsen, J. Vaage, Degree of phosphorylation of survival kinases in isolated mouse hearts depends on the mode of perfusion. Poster. Journal of Molecular and Cellular Cardiology, 44 (2008) 809-809. ISHR section meeting, Athens. Greece, 28-31th of May 2008.
A.M. Khalid, E. Aasum, A.D. Hafstad, T.S. Larsen. Reduced lipid supply without a concomitant reduced glucose supply fails to alter the metabolic phenotype of diabetic hearts. Poster. JMCC, 44 (2008) 803-803. ISHR section meeting, Athens. Greece, 28-31th of May 2008.
A.M. Khalid, E. Aasum, A.D. Hafstad, K. Clarke, R. Berge, T.S. Larsen. TTA is a pan PPAR ligand which markedly stimulates fatty acid oxidation following in vivo administration. Poster. Cardiovascular Drugs and Therapy, 22 (2008) 142-143. 6th annual meeting of the Society for Heart and Vascular Metabolism. Boston, Massachusetts, 29th of June-1st of July, 2008
A.D. Hafstad, A.M. Khalid, O.J. How, R. Berge, T.S. Larsen, E. Aasum, In vivo administration of tetradecylthioacetic acid (TTA) in mice causes cardiac inefficiency and reduced post-ischemic ventricular function. Poster. Journal of Molecular and Cellular Cardiology, 42 (2007) S63-S63.ISHR 27th section meeting, Padova, Italy, 20-22th of June 2007.
O.J. How, T.S. Larsen, A.D. Hafstad, A. Khalid, E.S.P. Myhre, D.L. Severson, E. Aasum, Rosiglitazone treatment improves cardiac efficiency and post-ischemic functional recovery in hearts from diabetic mice. Poster. Cardiovascular Drugs and Therapy, 20 (2006) 410-411. Society for Heart and Vascular Metabolism Meeting (SHVM). Semiahmoo, Washington, USA, 6-9th of September 2006.
A.D. Hafstad, A.M. Khalid. O.J. How, T.S. Larsen and E. Aasum . Changing myocardial energy utilization from fat to glucose improves post-ischemic recovery in hearts from type 2 diabetic (db/db) mice. Oral. JMCC 2006; 40 (6): N032. ISHR, 26 European Congress, Manchester, 14-17th of June, 2006)
E. Aasum, A.D. Hafstad, O.J. How A.M. Khalid., D.L. Severson, T.S. Larsen. Chronic and acute metabolic interventions improve cardiac metabolism and enhances cardiac efficiency and ischemic tolerance in type 2 diabetes. Oral. American Heart Association meeting, Circulation, 782 2006. AHA, Chicago, 12-15th of November 2006.
A.D. Hafstad, A.M. Khalid, O.J. How, T.S. Larsen, E. Aasum. Elevated glucose and insulin improves cardiac efficiency and post-ischemic functional recovery in perfused hearts from type 2 diabetic (db/db) mice. Poster. Cardiovascular Drugs and Therapy, 20 (2006) 408-409. Society for Heart and Vascular Metabolism Meeting (SHVM), Semiahmoo, Washington, USA, 6-9th of September 2006.
A.D. Hafstad, A.M. Khalid, D.S. Severson, O.J. How, T.S. Larsen, E. Aasum. Insulin sensitivity in hearts from type 2 diabetic (db/db) mice. Poster. Hjerteforum 2005 ;Volum 2.(178), Kardiologisk vintermøte; 2005, 28-30th of January 2005
M. Vader, M.F. Essop, A.D. Hafstad, T.S. Larsen, E. Aasum. Acute effects of ppar ligands on cardiac metabolism. Poster. Journal of Molecular and Cellular Cardiology, 38 (2005) 1077-1077. European Section of International Society for Heart Research, 21-25th of June 2006.
A.D. Hafstad, D.S. Severson, T.S. Larsen, E. Aasum. Hearts from type 2 diabetic (db/db) are highly sensitive to insulin. Poster. Heart Failure/ISHR ESC Meeting, 21-26th of June 2003.
E. Aasum, A.D. Hafstad, D.L. Severson, T.S. Larsen. Age-dependent changes in cardiac metabolism, function and sensitivity to ischemia-reperfusion in type 2 diabetic (db/db) mice. Poster. Journal of Molecular and Cellular Cardiology, 34 (2002) A3-A3. 22nd European Session Meeting ISHR, Szeged Hungary, 25-28th of June 2002.
E. Aasum, A.D. Hafstad, D.L. Severson. Measurements of metabolism and mechanical function in isolated hearts from genetically diabetic mice. Poster. Clinical and Experimental Pharmacology and Physiology, 29 (2002) A100-A101. The 3rd International Amsterdam Mouse Symposium, 13-15th of March 2002.
E. Aasum, A. Carley, A.D. Hafstad, D.L. Severson, T.S. Larsen, Hearts from diabetic (db/db) mice show progressive cardiomyopathy with an age-dependent decline in post-ischemic recovery, which is not reversed by metabolic remodelling with PPAR agonists. Poster. Circulation, 106 (2002) 54-55. American Heart Association Scientific Sessions 2002, 17-20th of November 2002.
Research interests
The research interest is within basal cardiac research with a focus on myocardial metabolism and the response to different cardiac stressors. The professor Hafstad lab has experimental expertise is in studying cardiac metabolism and energetics using the isolated working heart set up with a repertoire of experimental biochemical techniques, including high resolution respirometry. The research focus is around studying cardiac adaptation following different cardiac stressors such as exercise, hypertension, hypoxia, obesity and diabetes. The lab has through international collaborations also studied the role of ROS producing enzymes: the NADPH-oxidases as redox signals in control of cardiac metabolism in response to stressors. Lately, the lab has gained an interest in cardiotoxicity induced by anticancer therapies and the impact of sex-specific differences in heart failure, and has received funding to investigate the cardiometabolic response to anticancer therapies in cell lines and an animal model.
Teaching
Professor Hafstad has a long track-record for teaching and examining students at the UiT – The Arctic University of Norway in many subjects within physiology and at several courses. She has also worked as an external examinator and opponent at NTNU: Norwegian University of Science and Technology NTNU. She is the current leader for second year of medical school at the UiT and the exam committee in this subject. In 2017 she completed her teaching portfolio, and in 2020, she also completed the course in research supervision (UNIPED-600). She has considerable experience in supervising students at undergraduate and graduate levels.
PhD student and medical research students
2023-ongoing. Main supervisor Anne Cathrine Furuheim Bryn (cand.med.). Project title: Cardiometabolic remodelling following breast-cancer therapy. IMB, Faculty of Health sciences, UiT, Norway.
2022- ongoing: Assistant supervisor PhD student Nelsy Efundem Tabako-Foncha (M.Sc). Project title: The relationship of mitochondrial shape and function in heart failure. IMB, Faculty of Health sciences, UiT, Norway.
2020- ongoing: Main supervisor PhD student Cand Vet. Asad Akthtar (cand.vet and M.Sc). Project title: Cardiometabolic consequences of cancer therapy treatment. IMB, Faculty of Health sciences, UiT, Norway.
2022: Main supervisor PhD Synne S Hansen (cand.vet.). Thesis: Myocardial metabolic, structural, and functional remodelling following nutritional and hormonal stress. IMB. Faculty of Health sciences, UiT, Norway.
2021: Main supervisor Medical Research Student Cathrine Furuheim Bryn (cand.med.). Thesis: HER2-blockage and Anthracycline-induced metabolic remodeling of the heart. Faculty of Health sciences, UiT, Norway.
2019: Assistant supervisor PhD Tina M Pedersen (cand.vet.). Thesis: Cardiac remodelling in obesity- and angiotensin II-mediated heart failure. Faculty of Health sciences, UiT, Norway.
2017: Assistant supervisor medical research student Line Rossvoll (cand.med). Thesis: Elevation of fatty acids protects the diabetic heart against ischemic injury. Faculty of Health sciences, UiT, Norway.
2015: Assistant supervisor PhD Jim Lund (M.Sc). Thesis: Prevention of cardiac inefficiency in type 2 diabetes by means of high-intensity exercise training. Faculty of Health sciences, UiT, Norway.
I have been a supervisor for 22 master and undergraduate students in medicine, biomedicine and biology.
Teaching experience at specific courses
MED-2501 Medical school UiT. 2014-2023. Leader/exam comitte leader/Lecturing /case leader
ODO-2008 Odontology school UiT. 2022-2023. Leader/Exam comitee/Lecturing /Case leader
MBI-3016 Master Medical Physiology UiT. 2019-2023. Exam comitee/Case leader
MED-2520 International semester Medical school UiT. 2016-2023. Lecturing
ODO-3000 Master Midwife UiT. 2011-2023. Lecturing
MED-1501 Medical school UiT. 2013-2023. Lecturing, case/lab leader
MED-2510-3-6 Medical school UiT. 2014-2023. Lecturing /case leader
HEL-6320 Course in Laboratory sciences uiT. 2011-2017. Lecturing
ODO-2006 Odontology school UiT. 2014-2021. Exam comitee/Lecturing /Case leader
MED-400 course 14 Medical school UiT. 2010. Lecturing
MED 100 Medical school UiT. 2001-2012. Exam comitee/Lab/Case leader
MBI-3010 Advanced Methods for Experimental Biomedicine uiT. 2015. Lab leader
HEL-8014 Experimental animal science UiT. 2012-2017. Lecturing
MBI-8004 NorHeart PhD course UiT. 2015-2016 Lecturing, case/lab leader
BIOIN-101 Bioingenieer bachelor UiT. 2011-2015 Lecturing
RAD-1010 Radiography bachelor, UiT 2011-2015 Lecturing
PSY-2544, humanbiologi Psykologi embetsstudiet UiT. 2002-2013. Lecturing
Bio-104 Human Biology course bachelor UiT. 1998-1999. Case leader
Bio-271 Generell Fysiologi bachelor UiT. 1998-1999. Lecturing /case leader
Human Biologi 1-year Medical course bachelor UiT. 2002-2007. Lecturing